Quick Answer
Medline Inc. reported Total Revenue of $28.43 billion for fiscal year 2025.
Medline Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Revenue | $28.43B +11.5% |
$25.51B +9.8% |
$23.23B |
| Net Income | $1.16B | — | — |
| Diluted EPS | -$0.01 | — | — |
| Total Assets | $38.48B +7.0% |
$35.98B | — |
| Cash and Equivalents | $1.94B +874.4% |
$199.00M | — |
| Long-Term Debt | $12.48B -24.0% |
$16.42B | — |
| Stockholders Equity | $10.74B | — | — |
| Operating Income | $2.21B +3.1% |
$2.15B +71.7% |
$1.25B |
| Gross Profit | $7.52B +7.8% |
$6.98B +18.5% |
$5.88B |
- Medline Inc. reported Total Revenue of $28.43 billion for fiscal year 2025.
- Medline Inc. showed an increase of +11.5% in Total Revenue compared to the prior fiscal year.
- Medline Inc. reported Net Income of $1.16 billion for fiscal year 2025.
- Medline Inc. reported Diluted EPS of $0.01 per share (loss) for fiscal year 2025.
- Medline Inc. reported Total Assets of $38.48 billion for fiscal year 2025.
- Medline Inc. showed an increase of +7.0% in Total Assets compared to the prior fiscal year.
- Medline Inc. reported Cash and Equivalents of $1.94 billion for fiscal year 2025.
- Medline Inc. showed an increase of +874.4% in Cash and Equivalents compared to the prior fiscal year.
- Medline Inc. reported Long-Term Debt of $12.48 billion for fiscal year 2025.
- Medline Inc. showed a decrease of -24.0% in Long-Term Debt compared to the prior fiscal year.
- Medline Inc. reported Stockholders Equity of $10.74 billion for fiscal year 2025.
- Medline Inc. reported Operating Income of $2.21 billion for fiscal year 2025.
- Medline Inc. showed an increase of +3.1% in Operating Income compared to the prior fiscal year.
- Medline Inc. reported Gross Profit of $7.52 billion for fiscal year 2025.
- Medline Inc. showed an increase of +7.8% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: